Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-22-276966
Filing Date
2022-11-03
Accepted
2022-11-03 16:45:32
Documents
1
Group Members
FREDRIC N. ESHELMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d355027dsc13da.htm SC 13D/A 65513
  Complete submission text file 0001193125-22-276966.txt   67155
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Subject) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88067 | Film No.: 221358733
SIC: 2834 Pharmaceutical Preparations

Mailing Address 319 N. 3RD STREET, SUITE 301 WILMINGTON NC 28401
Business Address 319 N. 3RD STREET, SUITE 301 WILMINGTON NC 28401 910 558 6885
Eshelman Ventures, LLC (Filed by) CIK: 0001706673 (see all company filings)

EIN.: 000000000 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13D/A